Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
Conditions:
Dermatitis Atopic
Sponsor: Sanofi
trial.available_in:
БГ
Overview
Primary Objective:
To explore associations between biomarkers of atopic dermatitis (AD) and:
* Disease state and time course of AD,
* Disease state and evolution of selected atopic comorbid conditions,
* Effectiveness of specific AD treatments.
Description
The estimated enrollment duration is approximately 2 years, while duration of observation is approximately 5 years.
Who can participate
Inclusion criteria:
* Participation in the OBS15333 pediatric atopic dermatitis (AD) registry.
* Signed informed consent by the parent/legally acceptable representative and assent by the participant appropriate to the participant's age.
Exclusion criteria:
Not applicable.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Locations
9
Argentina (1)
Investigational Site Number : 0320002
Ciudad Autonoma de Buenos Aires , Buenos Aires
Australia (1)
Investigational Site Number : 0360001
Westmead , New South Wales
Brazil (1)
Universidade Federal do Paraná Site Number : 0760003
БГ